Credits: Canva
Quademic 2025: Hospitals in the United States are dealing with a surge in patients admission, the reason is the quademic it is dealing with at this moment. This has led to an influx of patients. It is all caused by seasonal infections, including common flu, Covid-19, and respiratory syncytial virus (RSV) that dominate the winter season in the US. This year, norovirus also joined the list, which has further increased the load on the healthcare.
The healthcare company founded in academics M Health Fairview, confirmed that their hospitals are overflowing due to the quademic.
The hospitals of M Health Fairview's volume is up by 30% and as a results, patients are being treated in the hallways and in alternative care areas. There is also a longer wait time and shortages for resources that are required to treat these emergencies. This has also impacted other life-threatening emergencies like heart attacks and strokes, as the healthcare resources and caregivers are occupied with the surge in seasonal cases.
ALSO READ: Birmingham Struggles With 4 Different Virus Hits, Know What They Are
Common cold and flu: The common cold and influenza (flu) are perhaps the most well-known illnesses that peak during the fall. As temperatures drop and humidity levels fluctuate, viruses that cause colds and the flu become more active. The flu, in particular, can be more severe than a common cold, leading to complications such as pneumonia, especially in vulnerable populations like the elderly and those with pre-existing health conditions. Symptoms include a runny nose, sore throat, coughing, fever, and body aches.
Covid-19: As per the World Health Organization, Coronavirus disease or COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with this virus will experience mild to moderate respiratory illness and recover without requiring special treatment, However, there could be some cases of seriously ill patients who may require medical attention. It is also because of the other existing medical conditions like cardiovascular diseases, diabetes, chronic respiratory diseases, cancers, or older age.
The best way to protect against this virus is by following social isolation form those who are infected, using mask to prevent droplets from infecting others when you cough or sneeze and to wash your hands for 20 seconds frequently.
RSV or Respiratory Syncytial Virus: As per the Centers of Diseases Control and Prevention (CDC), RSV is a common respiratory virus that infects nose, throat and lungs. Though symptoms are similar to the viruses like flu or COVID-19, the disease in itself is different. It also peaks during the winter season, especially between December and January.
However, the main difference between RSV and other respiratory illness, above mentioned is that RSV can cause pneumonia or bronchiolitis, especially for those who are over the age of 50 or with an existing heart or lung disease.
Norovirus: It is a number 1 cause of foodborne illness in the US and this happens when virus gets into the food and then it accidentally enters your mouth. These particles are from faeces or vomit from infected people, or can be transmitted via contaminated food and water. It could also spread by touching unclean surfaces like door handles or cutlery.
For most people, having norovirus is unpleasant, but mild and recovery could be made in 1 to 2 days. However, it could be more serious for babies, older people and anyone with any existing health condition.
Credit: https://anchor.humanbrain.in/
Researchers at the Indian Institute of Technology Madras (IIT Madras) have released the world’s most detailed 3D atlas of the human brainstem.
Called ANCHOR (Atlas of Neurochemical Characterization of the Human Brainstem with 3D Reconstruction), the atlas was developed using a high-throughput brain imaging and computing platform that transforms whole human brains into 3D cell-resolution atlases.
It provides comprehensive multi-modal 3D maps of the human brainstem across the lifespan, covering the prenatal period, childhood, and adulthood.
The atlas includes more than 200 brainstem nuclei and fiber tracts reconstructed from hundreds of serial sections. To identify distinct neurochemical cell types, researchers overlaid eight complementary immunostains across more than 500 sections, enabling detailed mapping.
Developed by the Sudha Gopalakrishnan Brain Centre (SGBC) at IIT Madras, ANCHOR has been made publicly available to researchers, clinicians, and patients worldwide.
“This is a significant accomplishment in the field of neurobiology. This is a multimodal framework integrating MRI, histology, and detailed chemo-architecture. It will be the most detailed and comprehensive maps of the human brainstem, and made available publicly in digital form. These maps will help in identifying specific cell populations affected in brain stem lesions, which could be critical for clinical applications,” said Prof. Ajay Kumar Sood, Principal Scientific Adviser to the Government of India, during the 3rd BRICS Neuroscience Symposium 2026.
Prof. Mohanasankar Sivaprakasam, Head of SGBC, IIT Madras, said the atlas uses a multimodal image visualization framework that integrates volumetric MRI data with cellular-level images.
“By establishing precise spatial correspondence across these modalities, the atlas enables a seamless transition from gross brain structures in the MRI to cellular-level features. We envision that these maps and atlases will have significant implications for neuroscience and neuromedicine,” he said.
The human brainstem contains more than 200 nuclei and fiber tracts and plays a vital role in regulating essential body functions.
ANCHOR is an online platform featuring more than 800 serial histological sections stained for Nissl and seven immunochemical (IHC) markers from three human brainstems representing different stages of life:
The atlas also describes catecholaminergic groups across all three age groups, identifies the protoplasmic commissural dendrites of the hypoglossal nucleus, and describes the pretectal nuclei in the fetal brainstem.
Read More:79th World Health Assembly: India Created Over 880 Million Digital Health IDs, Says J P Nadda
ANCHOR includes an online viewer that integrates:
Credit: iStock
The National Institute of Virology (NIV) in Pune has confirmed Nipah virus infection in a 43-year-old man from Ramanattukara in Kerala's Kozhikode district.
The patient, who was earlier shifted from a private hospital to a dedicated Nipah isolation facility at Kozhikode Government Medical College Hospital, remains in critical condition and is currently on ventilator support under the close supervision of a team of specialists, as per officials.
The patient was initially transferred to the Medical College Hospital after testing positive in a preliminary examination conducted at the Virus Research and Diagnostic Laboratory (VRDL). Following preliminary test results that suggested Nipah infection, the Kerala Health Department swung into action and intensified surveillance and containment measures in Kozhikode district.
After confirmation from NIV Pune, health authorities launched extensive contact-tracing efforts. District officials have identified 77 people who may have been exposed to the patient through contact tracing:
Notably, the patient's immediate family members—including his wife, two children, father, and mother—have been placed under quarantine.
In addition, two staff members of a private hospital in Kozhikode who interacted with the patient during earlier treatment have also been advised to remain in quarantine. Samples from five primary contacts have been sent to the VRDL laboratory for testing, as per media reports.
Also read: Ebola Survivors May Face COVID-Like Memory Loss and Brain Issues For Over 7 Years: NIH Study
As per District Collector M.S. Madhavikutty, none of the identified contacts are currently showing symptoms and there is no immediate need to declare a containment zone.
Health Minister K. Muraleedharan also stated that the current situation does not warrant the declaration of a containment zone in Ramanattukara.
"The 15 priority contacts have been advised to remain in quarantine. A rapid response team meeting was held to ensure the availability of PPE kits and gloves. There is no shortage of medicines, and additional supplies will arrive from Chennai," the minister said.
The patient's initial symptoms included a high fever about a week ago and was later hospitalized with symptoms suggestive of encephalitis. But as his condition worsened, doctors tested for Nipah infection, which turned positive.
He is likely to have been exposed to the virus while cleaning an old godown in Puthukad, Malappuram district, reportedly connected to his soap manufacturing business.
Another likely source of infection is a chikoo tree located on the patient's property, where officials have reportedly observed the presence of bats and bird droppings.
"Anyone developing fever should voluntarily isolate themselves, wear a mask, and avoid close contact with others. However, making masks mandatory for the public is not being considered at present, as the situation does not require such a measure," Madhavikutty told reporters.
This is the 11th Nipah outbreak reported in Kerala since the virus was first detected in the state in 2018.
According to the World Health Organization, Nipah virus is a zoonotic disease, meaning it can spread from animals to humans. It can also be transmitted through contaminated food and, in some cases, directly from person to person.
In humans, infection can range from asymptomatic illness to severe respiratory disease and fatal encephalitis (brain inflammation). The virus can also infect animals such as pigs, causing significant economic losses for farmers.
Although outbreaks have been limited mainly to parts of Asia, the virus is known for its high fatality rate and potential to cause severe disease.
Common symptoms include:
Nipah virus is considered a major public health threat because of:
Credit: AI generated image
People who survive Ebola virus disease (EVD) may continue to experience memory loss, irritability, and difficulty concentrating for more than seven years after recovering from the infection, according to a new study led by researchers at the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH).
The findings come as Ebola outbreaks continue in the Democratic Republic of Congo and Uganda, where confirmed cases have surpassed 650 and more than 130 deaths have been reported.
The NIH partnered with Liberia's Ministry of Health to study the long-term effects of the disease during the 2014–2016 Ebola epidemic in West Africa, which caused more than 28,000 infections and over 11,000 deaths across Liberia, Guinea, and Sierra Leone.
Researchers evaluated 148 adult Ebola survivors and 81 uninfected close contacts who served as a comparison group. The results revealed that many people experienced significant neurological symptoms during the acute phase of the illness, some of which continued for seven long years.
During infection, survivors commonly reported headaches, altered mental status, and stroke-like symptoms. Long-term complications affected the brain and nervous system and included cognitive dysfunction, persistent headaches, sleep disturbances, depression, sexual dysfunction, tremors, fatigue, cranial nerve abnormalities, and abnormal sensations.
The researchers also found that headaches and neurological abnormalities remained more common among Ebola survivors than in people who had not been infected.
"Over time, survivors' symptoms and neurological examinations improved; however, more than 7 years later, a significant proportion continue to endorse memory loss," the researchers wrote in the study, published in JAMA Neurology.
Also read: WHO Says Ebola Fight Is Catching Up; Expert Explains Science Behind Patient Recoveries
The study noted that many participants experienced symptoms similar to those seen in other post-infection conditions, including Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). These symptoms included headaches, memory loss, fatigue, and difficulty concentrating.
"This suggests possible shared pathophysiology, including persistent viral antigen or immune dysregulation," the researchers said.
However, the authors pointed out some important differences. While Long COVID and ME/CFS are often associated with autonomic nervous system dysfunction, such problems were not clearly identified among Ebola survivors, although dizziness and light-headedness were common.
The exact cause of long-term neurological problems after Ebola infection remains unclear. The researchers explained that during the acute illness, brain-related symptoms may be due to widespread inflammation, electrolyte imbalances, low blood pressure, blood-clotting abnormalities, or direct infection of the brain and nervous system by the virus.
On the other hand, long-term neurological issues may stem from persistent immune system changes, prolonged recovery from severe illness, or lingering viral material in the body.
Read More: Ebola Bundibugyo Outbreak: UK Scientists Identify 23 Unique Mutations
The researchers emphasized that neurological care should be a priority for clinicians treating Ebola survivors.
"Survivors experienced headaches, memory loss, and fatigue that may significantly impact quality of life," the authors wrote.
They noted that headaches often respond to standard preventive treatments, but survivors should continue to be monitored because of the rare risk of Ebola-related relapse in the central nervous system.
The study also found that many survivors experienced symptoms of depression, including suicidal thoughts. Because symptoms such as headaches, memory problems, concentration difficulties, and sleep disturbances can overlap with psychiatric disorders, the researchers stressed the importance of mental health evaluation and care.
Fortunately, many of these symptoms appear to improve or resolve over time with appropriate treatment and support.
The current Ebola outbreak is caused by the Bundibugyo strain, which differs from the strain responsible for the 2014–2016 West African epidemic. Unlike the Zaire strain, there are currently no approved vaccines or antiviral treatments specifically for Bundibugyo Ebola, although some patients have recovered.
Researchers believe many of the long-term neurological effects observed in survivors of the West African outbreak could also occur in Bundibugyo survivors.
© 2024 Bennett, Coleman & Company Limited